Medios AG Reports Strong Earnings Growth in 2024, Eyes Further Gains in 2025

Medios AG has announced its preliminary financial figures for 2024, showcasing a significant rise in revenue and EBITDA. The company, a key player in the Specialty Pharma sector in Europe, achieved a revenue increase to approximately €1.9 billion, marking a 5.5% gain from the previous year. EBITDA pre1 surged by 31% to reach around €79 million, with the margin improving to 4.2% from 3.4% in 2023.

This growth follows the strategic acquisition of the Ceban Group, fueling international expansion and boosting cash flow from operating activities to a record €74 million. Looking ahead, Medios AG forecasts a further 6% revenue increase in 2025, aiming for €2 billion, with a projected EBITDA pre1 growth to around €96 million.

The complete 2024 Annual Report will be available on March 25, 2025.